PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/9/2003

PHARMANIAGA BERHAD

Quarterly report for the financial period ended

30/09/2003
Quarter3
Financial Year End31/12/2003
The figureshave not been audited

Attachments

pharma_klse0309.doc
249 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/09/2003


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
30/09/2003 
30/09/2002 
30/09/2003 
30/09/2002 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
156,200
157,354
465,987
455,450
2Profit/(loss) before tax
16,917
19,525
48,177
49,883
3Profit/(loss)
after tax and minority
interest
11,226
12,073
31,261
30,562
4Net profit/(loss) for
the period
11,226
12,073
31,261
30,562
5Basic earnings/(loss) per share (sen)
11.20
12.10
31.20
30.60
6Dividend per share (sen)
6.00
3.75
6.00
3.75



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR
END
7
Net tangible assets per share (RM)

2.1100
1.8000

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my



Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced14 Nov 2003  
CategoryFinancial Results
Reference NoCR-031114-69434